ID: ALA4758585

Max Phase: Preclinical

Molecular Formula: C15H10N6OS

Molecular Weight: 322.35

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc2cncnc2c1)Nc1ccc2nnsc2c1

Standard InChI:  InChI=1S/C15H10N6OS/c22-15(19-11-3-4-12-14(6-11)23-21-20-12)18-10-2-1-9-7-16-8-17-13(9)5-10/h1-8H,(H2,18,19,22)

Standard InChI Key:  IELOOJVLRWOXGP-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain adjacent to zinc finger domain protein 1A 48 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.35Molecular Weight (Monoisotopic): 322.0637AlogP: 3.28#Rotatable Bonds: 2
Polar Surface Area: 92.69Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.21CX Basic pKa: 2.06CX LogP: 2.64CX LogD: 2.64
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: -1.92

References

1. Yang Z,Zhou Y,Zhong L.  (2021)  Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.,  33  [PMID:33333161] [10.1016/j.bmcl.2020.127745]

Source